Mesa Laboratories [MLAB] vs Keysight [KEYS] Detailed Stock Comparison
TLDR: Quick Comparison Summary
Based on 21 vital metrics comparison: Mesa Laboratories Inc. wins in 7 metrics, Keysight Technologies Inc. wins in 13 metrics, with 0 ties. Keysight Technologies Inc. appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Mesa Laboratories Inc. | Keysight Technologies Inc. | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 156.38 | 59.84 | Keysight Technologies Inc. |
| Price-to-Book Ratio | 3.01 | 9.38 | Mesa Laboratories Inc. |
| Debt-to-Equity Ratio | 91.07 | 44.67 | Keysight Technologies Inc. |
| PEG Ratio | -0.50 | 0.87 | Keysight Technologies Inc. |
| EV/EBITDA | 16.60 | 45.71 | Mesa Laboratories Inc. |
| Profit Margin (TTM) | 1.51% | 16.95% | Keysight Technologies Inc. |
| Operating Margin (TTM) | 12.25% | 16.31% | Keysight Technologies Inc. |
| EBITDA Margin (TTM) | 12.25% | 16.31% | Keysight Technologies Inc. |
| Return on Equity | 2.18% | 17.22% | Keysight Technologies Inc. |
| Return on Assets (TTM) | 2.47% | 5.82% | Keysight Technologies Inc. |
| Free Cash Flow (TTM) | $42.31M | $1.28B | Keysight Technologies Inc. |
| Dividend Yield | 0.99% | N/A | N/A |
| 1-Year Return | 8.63% | 121.68% | Keysight Technologies Inc. |
| Price-to-Sales Ratio (TTM) | 2.27 | 10.25 | Mesa Laboratories Inc. |
| Enterprise Value | $701.15M | $58.78B | Keysight Technologies Inc. |
| EV/Revenue Ratio | 2.83 | 10.36 | Mesa Laboratories Inc. |
| Gross Profit Margin (TTM) | 64.18% | 62.19% | Mesa Laboratories Inc. |
| Revenue per Share (TTM) | $45 | $33 | Mesa Laboratories Inc. |
| Earnings per Share (Diluted) | $0.65 | $5.67 | Keysight Technologies Inc. |
| Beta (Stock Volatility) | 0.89 | 1.15 | Mesa Laboratories Inc. |
| Short % of Float | 5.82% | 1.23% | Keysight Technologies Inc. |
Mesa Laboratories Inc. vs Keysight Technologies Inc. Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Mesa Laboratories Inc. | -1.33% | -4.04% | 7.89% | 31.78% | 33.73% | 31.03% |
| Keysight Technologies Inc. | 1.79% | 7.64% | 2.27% | 24.83% | 72.04% | 72.78% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Mesa Laboratories Inc. | 8.63% | -22.18% | -59.46% | -13.74% | 234.96% | 612.70% |
| Keysight Technologies Inc. | 121.68% | 112.71% | 137.77% | 1,082.30% | 1,078.72% | 1,078.72% |
Performance & Financial Health Analysis: Mesa Laboratories Inc. vs Keysight Technologies Inc.
| Metric | MLAB | KEYS |
|---|---|---|
| Market Information | ||
| Market Cap | $535.35M | $59.44B |
| Market Cap Category | Small cap | Large cap |
| 10 Day Avg. Volume | 89,033 | 1,043,697 |
| 90 Day Avg. Volume | 122,281 | 1,265,216 |
| Last Close | $104.08 | $356.94 |
| 52 Week Range | $55.45 - $113.99 | $152.85 - $370.17 |
| % from 52W High | -8.69% | -3.58% |
| All-Time High | $333.42 (Dec 27, 2021) | $370.17 (May 11, 2026) |
| % from All-Time High | -68.78% | -3.57% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.04% | 0.23% |
| Quarterly Earnings Growth | 0.04% | 0.66% |
| Financial Health | ||
| Profit Margin (TTM) | 0.02% | 0.17% |
| Operating Margin (TTM) | 0.12% | 0.16% |
| Return on Equity (TTM) | 0.02% | 0.17% |
| Debt to Equity (MRQ) | 91.07 | 44.67 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $33.79 | $36.18 |
| Cash per Share (MRQ) | $5.52 | $12.70 |
| Operating Cash Flow (TTM) | $41.53M | $1.47B |
| Levered Free Cash Flow (TTM) | $36.83M | $1.08B |
| Dividends | ||
| Last 12-Month Dividend Yield | 0.99% | N/A |
| Last 12-Month Dividend | $0.80 | N/A |
Valuation & Enterprise Metrics Analysis: Mesa Laboratories Inc. vs Keysight Technologies Inc.
| Metric | MLAB (Apr 24, 2026) | KEYS (Apr 24, 2026) |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 156.38 | 59.84 |
| Forward P/E | 18.86 | 32.83 |
| PEG Ratio | -0.50 | 0.87 |
| Price to Sales (TTM) | 2.27 | 10.25 |
| Price to Book (MRQ) | 3.01 | 9.38 |
| Market Capitalization | ||
| Market Capitalization | $535.35M | $59.44B |
| Enterprise Value | $701.15M | $58.78B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 2.83 | 10.36 |
| Enterprise to EBITDA | 16.60 | 45.71 |
| Risk & Other Metrics | ||
| Beta | 0.89 | 1.15 |
| Book Value per Share (MRQ) | $33.79 | $36.18 |
Financial Statements Comparison: Mesa Laboratories Inc. vs Keysight Technologies Inc.
Financial Metrics
Loading Financial Charts...
Revenue
Operating Margin
Profit Margin
Long Term Debt
Income Flow Analysis
Financial Statements Comparison
Income Statement
| Metric | MLAB (2025) | KEYS (2025) |
|---|---|---|
| Revenue/Sales | 240.98M | 5.38B |
| Cost of Goods Sold | 90.11M | 2.04B |
| COGS % of Revenue | 37.4% | 37.9% |
| Gross Profit | 150.87M | 3.34B |
| Gross Margin | 62.6% | 62.1% |
| Research & Development | 19.52M | 1.01B |
| Operating Income (EBIT) | 16.34M | 876.00M |
| Operating Margin | 6.8% | 16.3% |
| EBITDA | 39.46M | 1.45B |
| EBITDA Margin | 16.4% | 27.1% |
| Pre-Tax Income | 5.96M | 1.08B |
| Pre-Tax Income % of Revenue | 2.5% | 20.1% |
| Income Tax | 7.94M | 213.00M |
| Income Tax % of Revenue | 3.3% | 4.0% |
| Net Income (Profit) | -1.97M | 850.00M |
| Profit Margin | -0.8% | 15.8% |
Balance Sheet & Liquidity Metrics
| Metric | MLAB (2025) | KEYS (2025) |
|---|---|---|
| Cash & Equivalents | 27.32M | 1.87B |
| Total Current Assets | 102.69M | 4.35B |
| Total Current Assets % of Revenue | 42.6% | 80.9% |
| Total Current Liabilities | 163.96M | 1.85B |
| Total Current Liabilities % of Revenue | 68.0% | 34.4% |
| Long-Term Debt | 76.90M | 2.73B |
| Long-Term Debt % of Revenue | 31.9% | 50.7% |
| Total Shareholders Equity | 159.83M | 5.88B |
| Retained Earnings | -188.94M | 7.08B |
| Retained Earnings % of Revenue | -78.4% | 131.6% |
| Property, Plant & Equipment | 29.88M | 236.00M |
Cash Flow Statement Comparison
| Metric | MLAB (2025) | KEYS (2025) |
|---|---|---|
| Operating Cash Flow | 39.69M | 1.42B |
| Operating Cash Flow % of Revenue | 16.5% | 26.4% |
| Capital Expenditures | -4.25M | -128.00M |
| Free Cash Flow | 42.31M | 1.28B |
| FCF Margin | 17.6% | 23.8% |
| Debt Repayment | -115.81M | 0 |
| Common Stock Repurchase | N/A | -377.00M |
Short Interest & Institutional Ownership Analysis
| Metric | MLAB | KEYS |
|---|---|---|
| Shares Short | 220,739 | 1.85M |
| Short Ratio | 1.64 | 1.17 |
| Short % of Float | 5.82% | 1.23% |
| Shares Outstanding | 5.52M | 171.39M |
| Float Shares | 4.94M | 170.46M |
| % Held by Insiders | 5.44% | 0.59% |
| % Held by Institutions | 96.65% | 93.99% |
| % Held by Public | -2.09% | 5.42% |
Dividend Analysis & Yield Comparison: Mesa Laboratories Inc. vs Keysight Technologies Inc.
| Metric | MLAB | KEYS |
|---|---|---|
| Last 12-Month Dividend | $0.80 | N/A |
| Last 12-Month Dividend Yield | 0.99% | N/A |
| 3-Year Avg Annual Dividend | $0.69 | N/A |
| 3-Year Avg Dividend Yield | 0.15% | N/A |
| 3-Year Total Dividends | $2.08 | N/A |
| Ex-Dividend Date | Feb 27, 2026 | N/A |